Angiotensin	0	11	B-Gene_or_gene_product
II	12	14	I-Gene_or_gene_product
induces	15	22	O
soluble	23	30	O
fms	31	34	B-Gene_or_gene_product
-	34	35	I-Gene_or_gene_product
Like	35	39	I-Gene_or_gene_product
tyrosine	40	48	I-Gene_or_gene_product
kinase	49	55	I-Gene_or_gene_product
-	55	56	I-Gene_or_gene_product
1	56	57	I-Gene_or_gene_product
release	58	65	O
via	66	69	O
calcineurin	70	81	O
signaling	82	91	O
pathway	92	99	O
in	100	102	O
pregnancy	103	112	O
.	112	113	O

Maternal	115	123	O
endothelial	124	135	B-Tissue
dysfunction	136	147	O
in	148	150	O
preeclampsia	151	163	O
is	164	166	O
associated	167	177	O
with	178	182	O
increased	183	192	O
soluble	193	200	O
fms	201	204	B-Gene_or_gene_product
-	204	205	I-Gene_or_gene_product
like	205	209	I-Gene_or_gene_product
tyrosine	210	218	I-Gene_or_gene_product
kinase	219	225	I-Gene_or_gene_product
-	225	226	I-Gene_or_gene_product
1	226	227	I-Gene_or_gene_product
(	228	229	O
sFlt	229	233	B-Gene_or_gene_product
-	233	234	I-Gene_or_gene_product
1	234	235	I-Gene_or_gene_product
)	235	236	O
,	236	237	O
a	238	239	O
circulating	240	251	O
antagonist	252	262	O
of	263	265	O
vascular	266	274	B-Gene_or_gene_product
endothelial	275	286	I-Gene_or_gene_product
growth	287	293	I-Gene_or_gene_product
factor	294	300	I-Gene_or_gene_product
and	301	304	O
placental	305	314	B-Gene_or_gene_product
growth	315	321	I-Gene_or_gene_product
factor	322	328	I-Gene_or_gene_product
.	328	329	O

Angiotensin	330	341	B-Gene_or_gene_product
II	342	344	I-Gene_or_gene_product
(	345	346	O
Ang	346	349	B-Gene_or_gene_product
II	350	352	I-Gene_or_gene_product
)	352	353	O
is	354	356	O
a	357	358	O
potent	359	365	O
vasoconstrictor	366	381	O
that	382	386	O
increases	387	396	O
concomitant	397	408	O
with	409	413	O
sFlt	414	418	B-Gene_or_gene_product
-	418	419	I-Gene_or_gene_product
1	419	420	I-Gene_or_gene_product
during	421	427	O
pregnancy	428	437	O
.	437	438	O

Therefore	439	448	O
,	448	449	O
we	450	452	O
speculated	453	463	O
that	464	468	O
Ang	469	472	B-Gene_or_gene_product
II	473	475	I-Gene_or_gene_product
may	476	479	O
promote	480	487	O
the	488	491	O
expression	492	502	O
of	503	505	O
sFlt	506	510	B-Gene_or_gene_product
-	510	511	I-Gene_or_gene_product
1	511	512	I-Gene_or_gene_product
in	513	515	O
pregnancy	516	525	O
.	525	526	O

Here	527	531	O
we	532	534	O
report	535	541	O
that	542	546	O
infusion	547	555	O
of	556	558	O
Ang	559	562	B-Gene_or_gene_product
II	563	565	I-Gene_or_gene_product
significantly	566	579	O
increases	580	589	O
circulating	590	601	O
levels	602	608	O
of	609	611	O
sFlt	612	616	B-Gene_or_gene_product
-	616	617	I-Gene_or_gene_product
1	617	618	I-Gene_or_gene_product
in	619	621	O
pregnant	622	630	O
mice	631	635	B-Organism
,	635	636	O
thereby	637	644	O
demonstrating	645	658	O
that	659	663	O
Ang	664	667	B-Gene_or_gene_product
II	668	670	I-Gene_or_gene_product
is	671	673	O
a	674	675	O
regulator	676	685	O
of	686	688	O
sFlt	689	693	B-Gene_or_gene_product
-	693	694	I-Gene_or_gene_product
1	694	695	I-Gene_or_gene_product
secretion	696	705	O
in	706	708	O
vivo	709	713	O
.	713	714	O

Furthermore	715	726	O
,	726	727	O
Ang	728	731	B-Gene_or_gene_product
II	732	734	I-Gene_or_gene_product
stimulated	735	745	O
sFlt	746	750	B-Gene_or_gene_product
-	750	751	I-Gene_or_gene_product
1	751	752	I-Gene_or_gene_product
production	753	763	O
in	764	766	O
a	767	768	O
dose	769	773	O
-	773	774	O
and	775	778	O
time	779	783	O
-	783	784	O
dependent	784	793	O
manner	794	800	O
from	801	805	O
human	806	811	B-Organism
villous	812	819	O
explants	820	828	O
and	829	832	O
cultured	833	841	O
trophoblasts	842	854	B-Cell
but	855	858	O
not	859	862	O
from	863	867	O
endothelial	868	879	B-Cell
cells	880	885	I-Cell
,	885	886	O
suggesting	887	897	O
that	898	902	O
trophoblasts	903	915	B-Cell
are	916	919	O
the	920	923	O
primary	924	931	O
source	932	938	O
of	939	941	O
sFlt	942	946	B-Gene_or_gene_product
-	946	947	I-Gene_or_gene_product
1	947	948	I-Gene_or_gene_product
during	949	955	O
pregnancy	956	965	O
.	965	966	O

As	967	969	O
expected	970	978	O
,	978	979	O
Ang	980	983	B-Gene_or_gene_product
II	984	986	I-Gene_or_gene_product
-	986	987	O
induced	987	994	O
sFlt	995	999	B-Gene_or_gene_product
-	999	1000	I-Gene_or_gene_product
1	1000	1001	I-Gene_or_gene_product
secretion	1002	1011	O
resulted	1012	1020	O
in	1021	1023	O
the	1024	1027	O
inhibition	1028	1038	O
of	1039	1041	O
endothelial	1042	1053	B-Cell
cell	1054	1058	I-Cell
migration	1059	1068	O
and	1069	1072	O
in	1073	1075	O
vitro	1076	1081	O
tube	1082	1086	B-Tissue
formation	1087	1096	O
.	1096	1097	O

In	1098	1100	O
vitro	1101	1106	O
and	1107	1110	O
in	1111	1113	O
vivo	1114	1118	O
studies	1119	1126	O
with	1127	1131	O
losartan	1132	1140	B-Drug_or_compound
,	1140	1141	O
small	1142	1147	O
interfering	1148	1159	O
RNA	1160	1163	O
specific	1164	1172	O
for	1173	1176	O
calcineurin	1177	1188	B-Gene_or_gene_product
and	1189	1192	O
FK506	1193	1198	B-Drug_or_compound
demonstrated	1199	1211	O
that	1212	1216	O
Ang	1217	1220	B-Gene_or_gene_product
II	1221	1223	I-Gene_or_gene_product
-	1223	1224	O
mediated	1224	1232	O
sFlt	1233	1237	B-Gene_or_gene_product
-	1237	1238	I-Gene_or_gene_product
1	1238	1239	I-Gene_or_gene_product
release	1240	1247	O
was	1248	1251	O
via	1252	1255	O
Ang	1256	1259	B-Gene_or_gene_product
II	1260	1262	I-Gene_or_gene_product
type	1263	1267	I-Gene_or_gene_product
1	1268	1269	I-Gene_or_gene_product
receptor	1270	1278	I-Gene_or_gene_product
activation	1279	1289	O
and	1290	1293	O
calcineurin	1294	1305	O
signaling	1306	1315	O
,	1315	1316	O
respectively	1317	1329	O
.	1329	1330	O

These	1331	1336	O
findings	1337	1345	O
reveal	1346	1352	O
a	1353	1354	O
previously	1355	1365	O
unrecognized	1366	1378	O
regulatory	1379	1389	O
role	1390	1394	O
for	1395	1398	O
Ang	1399	1402	B-Gene_or_gene_product
II	1403	1405	I-Gene_or_gene_product
on	1406	1408	O
sFlt	1409	1413	B-Gene_or_gene_product
-	1413	1414	I-Gene_or_gene_product
1	1414	1415	I-Gene_or_gene_product
expression	1416	1426	O
in	1427	1429	O
murine	1430	1436	B-Organism
and	1437	1440	O
human	1441	1446	B-Organism
pregnancy	1447	1456	O
and	1457	1460	O
suggest	1461	1468	O
that	1469	1473	O
elevated	1474	1482	O
sFlt	1483	1487	B-Gene_or_gene_product
-	1487	1488	I-Gene_or_gene_product
1	1488	1489	I-Gene_or_gene_product
levels	1490	1496	O
in	1497	1499	O
preeclampsia	1500	1512	O
may	1513	1516	O
be	1517	1519	O
caused	1520	1526	O
by	1527	1529	O
a	1530	1531	O
dysregulation	1532	1545	O
of	1546	1548	O
the	1549	1552	O
local	1553	1558	O
renin	1559	1564	B-Gene_or_gene_product
/	1564	1565	O
angiotensin	1565	1576	B-Gene_or_gene_product
system	1577	1583	O
.	1583	1584	O

